LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
Clinical and Translational Medicine2022Vol. 12(1), pp. e703–e703
Citations Over TimeTop 1% of 2022 papers
Yiran Zhu, Bingluo Zhou, Xinyang Hu, Shilong Ying, Qiyin Zhou, Wenxia Xu, Lifeng Feng, Tianlun Hou, Xian Wang, Liyuan Zhu, Hongchuan Jin
Abstract
These results uncover a chemoresistant accelerating function of LNC942 in GC, and disrupting the LNC942-MSI2-c-Myc axis could be a novel therapeutic strategy for GC patients undergoing chemoresistance.
Related Papers
- → Ubiquitination and Degradation of Mutant p53(2007)224 cited
- → The Ubiquitin E3 Ligase MaLUL2 Is Involved in High Temperature-Induced Green Ripening in Banana Fruit(2020)22 cited
- → Promiscuous Interactions of gp78 E3 Ligase CUE Domain with Polyubiquitin Chains(2012)33 cited
- → The poxvirus encoded ubiquitin ligase, p28, is regulated by proteasomal degradation and autoubiquitination(2014)11 cited
- → The Antibiotic Treatment Index: A Novel Tool to Improve Antibiotic Resistance Monitoring(2014)